BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 24720530)

  • 1. Atopic dermatitis - all you can do from the outside.
    Gelmetti C; Wollenberg A
    Br J Dermatol; 2014 Jul; 170 Suppl 1():19-24. PubMed ID: 24720530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for atopic dermatitis.
    Ong PY
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):165-79. PubMed ID: 19216704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based treatment of atopic dermatitis with topical moisturizers.
    Micali G; Paternò V; Cannarella R; Dinotta F; Lacarrubba F
    G Ital Dermatol Venereol; 2018 Jun; 153(3):396-402. PubMed ID: 29368843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
    Kircik LH
    J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved clinical outcomes with moisturization in dermatologic disease.
    Ghali FE
    Cutis; 2005 Dec; 76(6 Suppl):13-8. PubMed ID: 16869177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Darrigade AS
    Ann Dermatol Venereol; 2019 Dec; 146(12S3):12S85-12S95. PubMed ID: 31997737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate.
    Luger TA
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):251-8. PubMed ID: 21294777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis.
    Diluvio L; Dattola A; Cannizzaro MV; Franceschini C; Bianchi L
    G Ital Dermatol Venereol; 2019 Feb; 154(1):32-36. PubMed ID: 30207438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical treatment of atopic dermatitis.
    Boguniewicz M
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):631-44, vi-vii. PubMed ID: 15474863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis.
    Hussain Z; Sahudin S; Thu HE; Shuid AN; Bukhari SN; Kumolosasi E
    Crit Rev Ther Drug Carrier Syst; 2016; 33(3):213-263. PubMed ID: 27910751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Community-based Assessment of Skin Care, Allergies, and Eczema (CASCADE): an atopic dermatitis primary prevention study using emollients-protocol for a randomized controlled trial.
    Eichner B; Michaels LAC; Branca K; Ramsey K; Mitchell J; Morris CD; Fagnan LJ; Dolor RJ; Elder N; Hahn DL; Nease DE; Lapidus J; Cibotti R; Block J; Simpson EL
    Trials; 2020 Mar; 21(1):243. PubMed ID: 32131885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
    Bomstein Y; Rozenblat S
    J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure.
    Kasai H; Kawasaki H; Fukushima-Nomura A; Yasuda-Sekiguchi F; Amagai M; Ebihara T; Tanese K
    Ann Med; 2021 Dec; 53(1):2205-2214. PubMed ID: 34797182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atopic Dermatitis.
    Clebak KT; Helm L; Uppal P; Davis CR; Helm MF
    Med Clin North Am; 2024 Jul; 108(4):641-653. PubMed ID: 38816108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
    Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
    J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Insights About Topical Treatment of Mild-to-Moderate Pediatric and Adult Atopic Dermatitis.
    Lynde CW; Bergman J; Fiorillo L; Guenther L; Keddy-Grant J; Landells I; Marcoux D; Ramien M; Rehmus W
    J Cutan Med Surg; 2019; 23(3_suppl):3S-13S. PubMed ID: 30965012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a protein-free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients.
    Wollenberg A; Fölster-Holst R; Saint Aroman M; Sampogna F; Vestergaard C
    J Eur Acad Dermatol Venereol; 2018 Apr; 32 Suppl 1():1-15. PubMed ID: 29533490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons.
    Frølunde AS; Thyssen JP; Deleuran M; Vestergaard C
    Am J Clin Dermatol; 2021 Nov; 22(6):775-783. PubMed ID: 34322849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.